论文部分内容阅读
目的:观察定量气雾剂(MDI)加储雾罐治疗婴幼儿喘息性疾病的疗效。方法:利用实验研究策略对172例患儿随机分为两组,均给予消炎、祛痰等治疗外,治疗组采用普米克、喘乐宁气雾剂加储雾罐吸入。对照组静输氨茶碱、硫酸镁或糖皮质激素,比较两组患儿用药后咳嗽、喘鸣音消失、呼吸困难改善情况及住院日数以及用药前后最大呼气流速(PEF值)变化。结果:治疗组咳嗽、喘鸣音消失、呼吸困难改善、住院日数与对照组相比,P<0.05,差异有显著意义。用药前后PEF值变化P<0.01,差异具有非常显著意义。结论:MDI加储雾罐吸入治疗婴幼儿喘息性疾病比传统疗法更有效、安全、副作用小、经济、方便,值得推广应用。
Objective: To observe the efficacy of quantitative aerosol (MDI) plus aerosol canister in the treatment of infantile asthmatic diseases. Methods: 172 cases of children were randomly divided into two groups by experimental study. All patients were given anti-inflammatory and expectorant treatment. The patients in the treatment group were treated with Pulmicort and Salbutamol aerosol plus aerosol canister. The control group received intravenous aminophylline, magnesium sulfate or glucocorticoid. The cough and wheeze disappeared after treatment, the improvement of dyspnea and hospitalization days, and the change of maximum expiratory flow rate (PEF) before and after treatment were compared between the two groups. Results: The treatment group cough, wheeze disappeared, dyspnea improved, hospitalization days compared with the control group, P <0.05, the difference was significant. PEF values before and after treatment P <0.01, the difference has a very significant meaning. Conclusion: MDI plus aerosol canister inhalation treatment of infantile asthmatic disease more effective than conventional therapy, safety, side effects, economical, convenient, it is worth promoting.